Graft-versus-host disease impairs vaccine responses through decreased CD4+ and CD8+ T cell proliferation and increased perforin-mediated CD8+ T cell apoptosis.
Graft-versus-host disease impairs vaccine responses through decreased CD4+ and CD8+ T cell proliferation and increased perforin-mediated CD8+ T cell apoptosis.
复制标题
DOI:
10.4049/jimmunol.1200391
复制
发表时间:
2013-02-01
期刊:
影响因子:
--
通讯作者:
Fry TJ
中科院分区:
文献类型:
--
作者:
Capitini CM;Nasholm NM;Duncan BB;Guimond M;Fry TJ
Tumor-targeted vaccines represent a strategy to enhance the graft-versus-leukemia effect following allogeneic blood or marrow transplantation (alloBMT). We have previously shown that GVHD can negatively impact quantitative responses to vaccines. Using a minor histocompatibility antigen (mHA)-mismatched BMT (B6 → B6 × C3H.SW) followed by adoptive transfer of HY-specific T cells and HY-expressing dendritic cells we assessed whether GVHD induced by donor lymphocyte infusion (DLI) affects the persistence, proliferation and survival of vaccine-responding, nonalloantigen reactive T cells. Both CD8+ and CD4+ HY-specific T cells undergo less vaccine-driven proliferation in allogeneic recipients with GVHD. While vaccine responding CD8+ T cells show decreased gamma interferon and CD107a production, CD4+ T cells exhibit increased PD-1 and TIM3 expression. In addition, the degree of apoptosis in vaccine-responding CD8+ T cells was higher in the presence of GVHD, but there was no difference in CD4+ T cell apoptosis. Using Fas ligand-deficient or TRAIL-deficient DLI had no impact on apoptosis of HY-specific T cells. However, perforin-deficient alloreactive DLI induced significantly less apoptosis of vaccine-responding CD8+ T cells, and resulted in enhanced tumor protection. Thus, diminished vaccine responses during GVHD result from impaired proliferation of CD8+ and CD4+ T cells responding to vaccination, with an additional contribution from perforin-mediated CD8+ T cell apoptosis. These results provide important insights towards optimizing vaccine responses after alloBMT.
登录
查看更多内容
DOI:
10.1084/jem.183.6.2645
发表时间:
1996-06-01
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Baker MB;Altman NH;Podack ER;Levy RB
通讯作者:
Levy RB
DOI:
10.1158/1078-0432.ccr-08-3332
发表时间:
2009-08-01
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
Beatty GL;Smith JS;Reshef R;Patel KP;Colligon TA;Vance BA;Frey NV;Johnson FB;Porter DL;Vonderheide RH
通讯作者:
Vonderheide RH
影响因子:
30.5
作者:
Lantz, O;Grandjean, I;Di Santo, JP
通讯作者:
Di Santo, JP
影响因子:
32.4
作者:
Grossman, WJ;Verbsky, JW;Ley, TJ
通讯作者:
Ley, TJ
影响因子:
20.3
作者:
Jenq, Robert R.;King, Christopher G.;van den Brink, Marcel R. M.
通讯作者:
van den Brink, Marcel R. M.